Latest:
Press ReleasesHealthcare

Next-generation Sequencing Library Preparation Market Size to Surpass USD 6.44 Billion by 2034

Rohan 165 Views 7 min read

The global next-generation sequencing (NGS) library preparation market is gaining momentum with a valuation of USD 2.07 billion in 2025 and a projected CAGR of 13.47%, expected to reach USD 6.44 billion by 2034. This expansion is driven by relentless demand for precision genomic analysis, increased adoption of automation in laboratories, and a rapid evolution of sequencing technologies.

Next-generation Sequencing Library Preparation Market Size 2025 to 2034

Introduction: Where Innovation Meets Genomics

Powered by growing clinical research needs, personalized medicine, and advancements in sequencing workflows, NGS library preparation has become foundational to modern healthcare and biotechnology. Leading companies are responding with next-generation kits and automation platforms that streamline processes, enhance reproducibility, and unlock new discoveries.

Next-generation Sequencing Library Preparation Market Key Insights

  • Market size in 2025: USD 2.07 billion; projected to reach USD 2.34 billion in 2026 and USD 6.44 billion by 2034.

  • North America holds the largest regional share (44% in 2024), thanks to robust infrastructure and strong R&D investment.

  • Asia Pacific is the fastest-growing region, set for a 15% CAGR from 2025 to 2034.

  • Library preparation kits lead the product type segment (50% market share in 2024).

  • Illumina platforms dominate sequencing compatibility (45% share in 2024); Oxford Nanopore is the fastest-growing technology.

  • Clinical research drives application growth, capturing 40% share in 2024.

  • Hospitals and clinical laboratories remain the top end users (42% share in 2024).

  • Automated/high-throughput preparation methods are surging at a forecast CAGR of 14%.

Next-generation Sequencing Library Preparation Market Size & Regional Breakdown

Year Global Market Value North America Market Value
2025 USD 2.07 Billion USD 683.1 Million
2034 USD 6.44 Billion USD 2,163.68 Million
CAGR 13.47% 13.67%
North America’s dominance is driven by advanced genomics facilities and heavy investment in precision medicine, while Asia Pacific’s rapid growth reflects heightened funding in biotechnologies and government support for genomics.

AI’s Transformative Role in NGS Library Preparation

AI algorithms are increasingly embedded in NGS library preparation workflows, enabling real-time quality control and automated troubleshooting. By optimizing reagent volumes, sequencing reads, and sample allocation, AI streamlines pipelines for hospitals, research labs, and biotech companies alike.

Moreover, machine learning platforms drive efficient genomic data analysis, helping researchers decipher complex genetic patterns and accelerate clinical diagnostics. This integration is poised to reduce costs, improve turnaround times, and enhance diagnostic accuracy—paving the way for scalable, personalized medicine.

What’s Powering Market Growth?

Increased demand for high-throughput, precise genomic sequencing is at the market’s core, spurred by trends in precision medicine, biomarker discovery, and infectious disease surveillance. Automation and microfluidics are revolutionizing workflows, reducing manual errors and supporting scalability for drug discovery and patient diagnostics. The shift toward sustainable, lyophilized kits also cuts costs by eliminating cold-chain requirements.

Why Are Lyophilized and Miniaturized Kits Trending?

Lyophilized NGS library prep kits, recently launched by industry leaders such as Meridian Bioscience, eliminate cold-chain constraints, lowering shipping costs and environmental impact. Miniaturization, enabled by microfluidics, conserves reagents and guarantees consistency across sample batches, supporting the market’s eco-friendly evolution.

Are Startups and AI Driving Innovation?

Startups are propelling innovation by introducing automation platforms and AI-powered solutions for easier, faster, and more accurate library preparation. Increased funding is boosting development of kits that support single-cell and spatial genomics, providing new insights for oncology and rare disease research.

What Are the Key Market Segmentation Trends?

  • Product Types: Library prep kits, automation instruments, reagents, and microfluidics platforms enable tailored workflows for genetic, cancer, and rare disease sequencing.

  • Technology Compatibility: Illumina platforms maintain dominance, but Oxford Nanopore and PacBio’s long-read sequencing solutions are rapidly gaining traction.

  • Applications: Clinical research, infectious disease monitoring, pharma R&D, and personalized medicine lead adoption, with academic labs following suit.

  • End Users: Hospitals, clinical labs, and biotech firms remain primary users, while CROs and academic institutes increase their investment in high-throughput solutions.

  • Preparation Types: Manual/bench-top methods remain popular for small-scale, customized workflows, while automated/high-throughput options are trending for scalability.

What Challenges and Cost Pressures Impact Growth?

Market growth faces challenges such as high costs of reagents and automation instruments, complex workflow validation requirements, and sustainability pressures related to plastic and reagent use. Ensuring compatibility across platforms and minimizing turnaround time are key pain points for labs wishing to scale up genomic analysis.

Which Companies Are Leading the Next-generation Sequencing Library Preparation Market?

Major Market Leaders

  • Illumina, Inc.

  • Thermo Fisher Scientific

  • Agilent Technologies

  • QIAGEN

  • 10x Genomics

Notable Innovators

  • Beckman Coulter

  • BGI Group

  • Bio-Rad Laboratories

  • F. Hoffmann-La Roche

  • Hamilton Company

  • New England Biolabs

  • Oxford Nanopore Technologies

  • Pacific Biosciences (PacBio)

  • PerkinElmer

  • Takara Bio

  • Tecan Group

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7044

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344

Rohan
Rohan
Principal Consultant at Market Stats Insight
Rohan Patil is a seasoned Healthcare Principal Consultant at Market Stats Insight and Precedence Research, with more than 5 years of experience in market intelligence and strategic insights. Holding a BSc in Biotechnology and an MBA in Marketing, he combines scientific expertise with business acumen to deliver data-driven analysis. Rohan specializes in the medical device sector and closely tracks innovations shaping the future of healthcare. His research helps global clients identify growth opportunities, assess risks, and stay competitive in a rapidly evolving market landscape.
Rohan
Latest posts by Rohan (see all)

Rohan

Rohan Patil is a seasoned Healthcare Principal Consultant at Market Stats Insight and Precedence Research, with more than 5 years of experience in market intelligence and strategic insights. Holding a BSc in Biotechnology and an MBA in Marketing, he combines scientific expertise with business acumen to deliver data-driven analysis. Rohan specializes in the medical device sector and closely tracks innovations shaping the future of healthcare. His research helps global clients identify growth opportunities, assess risks, and stay competitive in a rapidly evolving market landscape.